VAERS Explorer
Back to explore

Report #2896587

Received May 14, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
OH
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (ADACEL)SANOFI PASTEURUNK

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

ADACEL was prepared but the initial patient ultimately refused and the vaccine was placed back inside the fridge/and it was administered to another patient, with no reported adverse event; Initial information received on 04-May-2026 regarding an unsolicited non-valid non-serious case received from other or unknown health care professional. This case involves an unknown age patient of unknown gender who received Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] (Adacel) which was initially prepared for other patient, but patient ultimately refused and the vaccine was placed back inside the fridge for 24 hours, with no reported adverse event. The patient's past medical history, past drugs, vaccination(s), family history, and concomitant medications were not provided. On an unknown date, the patient received an unknown dose of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine, suspension for injection of unknown strength, (batch/lot number and expiry date: unknown) via an unknown route in an unknown vaccination site for immunisation [Immunisation], which was initially prepared for other patient, but patient ultimately refused and the vaccine was placed back inside the fridge for 24 hours, with no reported adverse event. (Product storage error) (latency: Same day). Information regarding batch number corresponding to the one at time of event occurrence is requested. Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.